U.S., July 23 -- ClinicalTrials.gov registry received information related to the study (NCT07079228) titled 'A Study to Compare QLS31905 and Chemotherapy With Placebo and Chemotherapy in Participants With Pancreatic Cancer' on July 13.
Brief Summary: The goal of this study is to evaluate the efficacy of QLS31905 in combination with chemotherapy (nab-paclitaxel plus gemcitabine [AG]) versus placebo in combination with chemotherapy (AG) in the treatment of CLDN18.2-positive advanced pancreatic cancer in adult participants.
Study Start Date: Sept., 2025
Study Type: INTERVENTIONAL
Condition:
Pancreatic Cancer
Intervention:
DRUG: QLS31905
QLS31905 will be administered as an IV infusion.
DRUG: Nab-paclitaxel.
Nab-paclitaxel will be admi...